The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya ...

As per the order based on insights from the National Centre for Vector Borne Disease Control, dengue and chikungunya are now ...

JEYPORE: District health administration is on high alert after at least 23 residents of Rathasharma colony in Koraput town ...

The EMA now advises against using the drug for people aged over 65 after 17 serious adverse effects were recorded in this age ...

CHIKV can trigger long-term joint pain that mimics autoimmune diseases like rheumatoid arthritis, potentially due to ...

Bhopal: In Madhya Pradesh, chikungunya cases have risen significantly, matching the increase in dengue infections, creating ...

MALKANGIRI: At least 235 people in Podia village, around 70 km from Malkangiri town, have reportedly developed symptoms of ...

Infectious disease stocks stumbled in the early months of 2025, with the BioWorld Infectious Disease Index (BIDI) plunging 17.83% by the end of April, well behind the broader markets. By comparison, ...

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

The approval applies to anyone aged 18 and older who has a risk of being exposed to the virus. But the FDA and the Centers ...